Phase 2 Readout
SKYE: Phase 2 Readout: nimacimab
September 30, 2026 · nimacimab. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- September 30, 2026
- Company
- Skye Bioscience, Inc. (SKYE)
- Drug
- nimacimab
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: nimacimab
- Company
- Skye Bioscience, Inc. (SKYE)
- Drug
- nimacimab
- Indication
- obesity